Impact of Probiotic B. infantis EVC001 Feeding in Premature Infants on the Gut Microbiome, Nosocomially Acquired Antibiotic Resistance, and Enteric Inflammation

Abstract

<b>Background:</b> Preterm birth is a major determinant of neonatal survival and morbidity, but the gut microbiome and associated enteric inflammation are also key factors in neonatal development and the risk of associated morbidities. We prospectively and longitudinally followed two cohorts of preterm infants, one of which was fed activated <i>Bifidobacterium longum</i> subsp. <i>infantis</i> (<i>B. infantis</i>) EVC001 8 × 10⁹ CFU daily, and the other was not fed a probiotic. Hospital feeding protocol assigned all infants born at <1500 g and/or < 32 weeks corrected gestational age to the probiotic feeding protocol, whereas infants born at >1500 g and/or >32 weeks corrected gestational age were not fed a probiotic. Fecal samples were opportunistically collected from 77 infants throughout the hospital stay, and subjected to shotgun metagenomic sequencing and quantification of enteric inflammation. De-identified metadata was collected from patient medical records. <b>Results:</b> The gut microbiome of preterm infants was typified by a high abundance of <i>Enterobacteriaceae</i> and/or <i>Staphylococcaceae</i>, and multivariate modeling identified the probiotic intervention, rather than degree of prematurity, day of life, or other clinical interventions, as the primary source of change in the gut microbiome. Among infants fed <i>B. infantis</i> EVC001, a high abundance of total <i>Bifidobacteriaceae</i> developed rapidly, the majority of which was <i>B. infantis</i> confirmed via subspecies-specific qPCR. Associated with this higher abundance of <i>Bifidobacteriaceae</i>, we found increased functional capacity for utilization of human milk oligosaccharides (HMOs), as well as reduced abundance of antibiotic resistance genes (ARGs) and the taxa that harbored them. Importantly, we found that infants fed <i>B. infantis</i> EVC001 exhibited diminished enteric inflammation, even when other clinical variables were accounted for using multivariate modeling. <b>Conclusion:</b> These results provide an important observational background for probiotic use in a NICU setting, and describe the clinical, physiological, and microbiome-associated improvements in preterm infants associated with <i>B. infantis</i> EVC001 feeding.